
This book reviews the latest research and trends in the field, with sections on research and development, medical department issues, regulatory aspects, and pharmacoeconomic and other issues. This edition has totally revised chapters on drug regulation in the USA, and new contributions regarding pharmaco-economics in two new chapters
